Cancer incidence in people with affective disorder: Nationwide cohort study in Taiwan, 1997-2010

British Journal of Psychiatry

Volumn 205, Issue 3, 2014, Pages 183-188

  Hung, Yen Ni ^a,b,c   Yang, Shu Yu ^c,d   Huang, Ming Chyi ^a   Lung, For Wey ^d   Lin, Shih Ku ^a   Chen, Kuan Yu ^c   Kuo, Chian Jue ^e   Chen, Ying Yeh ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BIPOLAR DISORDER; BLADDER CANCER; BRAIN TUMOR; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HOLISTIC CARE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIFESTYLE; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; MOUTH CANCER; MYELOID LEUKEMIA; NOSE CAVITY CANCER; PANCREAS CANCER; PARANASAL SINUS CANCER; PATIENT CARE; PROSTATE CANCER; SKIN CANCER; SMOKING; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; SUBSTANCE USE; TAIWAN; TAIWANESE; TERMINAL DISEASE; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; VERY ELDERLY; ADOLESCENT; COMORBIDITY; FACTUAL DATABASE; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; MOOD DISORDERS; NEOPLASMS; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOOD DISORDERS; NEOPLASMS; RISK; TAIWAN; YOUNG ADULT;

EID: 84906984034     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.144741     Document Type: Article

References (40)

1. Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet 2002; 359: 241-7.
2. Bai YM, Su TP, Chen MH, Chen TJ, Chang WH. Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: a 10-year nationwide population-based prospective cohort study. J Affect Disord 2013; 150: 57-62.
3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
4. Jane-Llopis E, Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006; 25: 515-36.
5. Dreyer L, Winther JF, Andersen A, Pukkala E. Avoidable cancers in the Nordic countries. Alcohol consumption. APMIS Suppl 1997; 76: 48-67.
6. Dreyer L, Winther JF, Pukkala E, Andersen A. Avoidable cancers in the Nordic countries. Tobacco smoking. APMIS Suppl 1997; 76: 9-47.
7. Whitley E, Batty GD, Mulheran PA, Gale CR, Osborn DP, Tynelius P, et al. Psychiatric disorder as a risk factor for cancer: different analytic strategies produce different findings. Epidemiology 2012; 23: 543-50.
8. Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB, Johansen C. Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993. Am J Epidemiol 2002; 155: 1088-95.
9. Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol 2012; 92: 959-75.
10. Tsai SY, Chung KH, Wu JY, Kuo CJ, Lee HC, Huang SH. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J Affect Disord 2012; 136: 110-6.
11. BarChana M, Levav I, Lipshitz I, Pugachova I, Kohn R, Weizman A, et al. Enhanced cancer risk among patients with bipolar disorder. J Affect Disord 2008; 108: 43-8.
12. McGinty EE, Zhang Y, Guallar E, Ford DE, Steinwachs D, Dixon LB, et al. Cancer incidence in a sample of Maryland residents with serious mental illness. Psychiatr Serv 2012; 63: 714-7.
13. Chen YH, Lin HC. Increased risk of cancer subsequent to severe depression-a nationwide population-based study. J Affect Disord 2011; 131: 200-6.
14. Rosenshfir E, Shemesh P, Aizenberg D, Barak Y. Reduced risk of cancer in patients with bipolar affective disorder. Neurosci & Med 2011; 2: 57-60.
15. Liang JA, Sun LM, Muo CH, Sung FC, Chang SN, Kao CH. The analysis of depression and subsequent cancer risk in Taiwan. Cancer Epidemiol Biomarkers Prev 2011; 20: 473-5.
16. Possel P, Adams E, Valentine JC. Depression as a risk factor for breast cancer: investigating methodological limitations in the literature. Cancer Causes Control 2012; 23: 1223-9.
17. Tsai SY, Yang YY, Kuo CJ, Chen CC, Leu SJ. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord 2001; 64: 185-93.
18. Hsieh MH, Tang CH, Hung ST, Lee IH, Lin YJ, Yang YK. Comorbid prevalence of alcohol dependence, substance abuse, and external cause of injury in patients with bipolar disorder in a nationwide representative sample in Taiwan. Bipolar Disord 2012; 14: 677-9.
19. Bai YM, Lin CC, Hu PG, Yeh HS. Risk factors for substance use disorders among inpatients with major affective disorders in Taiwan Chinese. Gen Hosp Psychiatry 1998; 20: 377-80.
20. Gau SS, Chao PF, Lin YJ, Chang CJ, Gau CS. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study. J Clin Psychopharmacol 2008; 28: 509-17.
21. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-9). WHO, 1978.
22. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004; 83 : 1-1438.
23. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007; 8: 292-3.
24. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum 2010; 96 : 3-1383.
25. Woo HD, Kim J. Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLoS One 2013; 8: e75604.
26. Rothman KJ, Greenland S. Modern Epidemiology (2nd edn). Lippincott Williams & Wilkins, 1998.
27. Tang CH, Hsieh MH, Hung ST, Lee IH, Lin YJ, Yang YK. One-year post-hospital medical costs and relapse rates of bipolar disorder patients in Taiwan: a population-based study. Bipolar Disord 2010; 12: 859-65.
28. Vuorilehto MS, Melartin TK, Isometsa ET. Course and outcome of depressive disorders in primary care: a prospective 18-month study. Psychol Med 2009; 39: 1697-707.
29. Heffner JL, Strawn JR, DelBello MP, Strakowski SM, Anthenelli RM. The co?occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disord 2011; 13: 439-53.
30. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness. JAMA 2000; 284: 2606-10.
31. Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006; 67: 247-57.
32. Wang PW, Lin HC, Yeh YC, Liu TL, Yen CF. The relation of substance use with different levels of depressive symptoms and the moderating effect of sex and age in Taiwanese adolescents. Compr Psychiatry 2012; 53: 1013-20.
33. Oerlemans ME, van den Akker M, Schuurman AG, Kellen E, Buntinx F. A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health 2007; 3: 29.
34. Horwath E, Weissman MM. Epidemiology of depression and anxiety disorders. In Textbook in Psychiatric Epidemiology (eds MT Tsuang, M Tohen and GEP Zahner): 317-44. Wiley-Liss, 1995.
35. Catts V, Catts S, O'toole B, Frost A. Cancer incidence in patients with schizophrenia and their first?degree relatives-a meta?analysis. Acta Psychiatr Scand 2008; 117: 323-36.
36. Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 2001; 58: 573.
37. Barak Y, Achiron A, Mandel M, Mirecki I, Aizenberg D. Reduced cancer incidence among patients with schizophrenia. Cancer 2005; 104: 2817-21.
38. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Arch Gen Psychiatry 2007; 64: 1368-76.
39. Lin GM, Chen YJ, Kuo DJ, Jaiteh LE, Wu YC, Lo TS, et al. Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009. Schizophr Bull 2013; 39: 407-16.
40. Chen YJ, Wu CY, Chen TJ, Shen JL, Chu SY, Wang CB, et al. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J Am Acad Dermatol 2011; 65: 84-91.